Biochemical analysis by calcium determination on the newly formed bone in critical bone defects submitted to different treatments. A pilot study

International Journal of Morphology

Volumn 25, Issue 3, 2007, Pages 511-518

  Issa, João Paulo Mardegan ^a   Petenusci, Sérgio Olavo ^a   Siéssere, Selma ^a   Regalo, Simone Cecílio Hallak ^a   Lopes, Ruberval Armando ^a   Di Matteo, Miguel Angel Sala ^a   Iyomasa, Mamie Mizusaki ^a   Defino, Helton Luiz Aparecido ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Biomaterials; Bone repair; Calcium; Carriers; RhBMP 2

Indexed keywords

EID: 36149000982     PISSN: 07179367     EISSN: 07179502     Source Type: Journal    
DOI: 10.4067/S0717-95022007000300006     Document Type: Article

References (46)

1. Bhattarai, N.; Ramay, H. R.; Gunn, J.; Matsen, F. A. & Zhang, M. PEG-grafted chitosan as an injectable thermosensitive hydrogel for sustained protein release. J. Control. Release., 103:609-24, 2005.
2. Bohorquez, M.; Kock, C.; Tryastad, T. & Pandit, N. A study of the temperature-dependent micellization of Pluronic F-127. J. Colloid. Interf. Sci., 216:34-40, 1999.
3. Bonacucina, G.; Palmieri, G. F. & Craig, D. Q. Rheological and dielectric characterization of monoolein/water mesophases in the presence of a peptide drug. J. Pharm. Sci., 94:2452-62, 2005.
4. Boyd, B. J.; Whittaker, D.V.; Khoo, S. M. & Davey, G. Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems. Int. J. Pharm., 309:218-26, 2006.
5. Ganem-Quintanar, A.; Quintanar-Guerrero, D. & Buri, P. Monoolein: a review of the pharmaceutical applications. Drug. Dev. Ind. Pharm., 26:809-20, 2000.
6. Geraghty, P. G.; Attwood, D.; Collett, J. H.; Sharma H. & Dandiker, Y. An investigation of the parameters influencing the bioadhesive properties of Myverol 18-99/water gels. Biomaterials, 18:63-7, 1997.
7. Hejazi, R. & Amiji, M. Chitosan-based gastrointestinal delivery systems. J. Control. Release, 89:151-65, 2003.
8. Hogan, B.L. Bone morphogenetic proteins in development. Curr. Opin. Genet. Dev., 6:432-8, 1996.
9. Inoda, H.; Yamamoto, G. & Hattori, T. Histological investigation of osteoinductive properties of rhBMP-2 in a rat calvarial bone defect model. J. Craniomaxillofac. Surg., 32:365-9, 2004.
10. Johnston, T. P. & Miller, S. C. Toxicological evaluation of Poloxamer vehicle for intramuscular use. J. Parent. Sci. Technol., 39:230-41, 1985.
11. Kao, H. J.; Lin, H. R.; Lo, Y. L. & Yu, S. P. Characterization of pilocarpine-loaded chitosan/Carbopol nanoparticles. J. Pharm. Pharmacol., 58:179-86, 2006.
12. Kim, H. D. & Valentini, R. F. Retention and activity of BMP-2 in hyaluronic acid-based scaffolds in vitro. J. Biomed. Mater. Res., 59:573-84, 2002.
13. Kofuji, K.; Murata, Y. & Kawashima, S. Sustained insulin release with biodegradation of chitosan gel beads prepared by copper ions. Int. J. Pharmacol., 303:95-103, 2005.
14. Kuboki, Y.; Jin, Q. & Takita, H. Geometry of carriers controlling phenotypic expression in BMP-induced osteogenesis and chondrogenesis. J. Bone. Joint. Surg. Am., 83A (Suppl 1):S105-S15, 2001.
15. Lara, M. G.; Bentley, M.V. L. B. & Collett, J. H. In vitro drug release mechanism and drug loading studies of cubic phase gels. Int. J. Pharm., 293:241-50, 2005.
16. Lee, J. & Kellaway, I.W. Buccal permeation of [D-Ala2, D-Leu5] enkephalin from liquid crystalline phases of glyceryl monooleate. Int. J. Pharm., 195:35-8, 2000a.
17. Lee, J. & Kellaway, I.W. Combined effect of oleic acid and polyethylene glycol 200 on buccal permeation of [D-Ala2, D-Leu5] enkephalin from a cubic phase of glyceryl monooleate. Int. J. Pharm., 204:137-44, 2000b.
18. Lee, J.; Young, S. A. & Kellaway, I.W. Water quantitatively induces the mucoadhesion of liquid crystalline phases of glyceryl monoleate. J. Pharm. Pharmacol., 53:629-36, 2001.
19. Lee, S. J.; Kim, S. W.; Chung, H.; Park, Y.T.; Choi, Y. W.; Choi, Y. W.; Cho, Y. H. & Yoon, M. S. Bioadhesive drug delivery system using glyceryl monooleate for the intravesical administration of paclitaxel. Chemotherapy, 51:311-8, 2005.
20. Mahmood, J.; Takita, H.; Ojima, Y.; Kobayashi, M.; Kohgo, T. & Kuboki, Y. Geometric effect of matrix upon cell differentiation: BMP-induced osteogenesis using a new bioglass with a feasible structure. J. Biochem., 129:163-71, 2001.
21. Mi, F. L.; Tan, Y. C.; Liang, H. C. & Sung, H.W. In vitro biocompatibility and degradation of a novel injectable-chitosan-based implant. Biomaterials, 23:181-91, 2002.
22. Moore, T.; Croy, S.; Mallapragada, S. & Pandit, N. Experimental investigation and mathematical modeling of Pluronic F-127 gel dissolution: drug release in stirred system. J. Control. Release, 67:191-202, 2000.
23. Nielsen, L. S.; Schubert, L. & Hansen, J. Bioadhesive drug delivery systems. I. Characterization of muco adhesive properties of systems based on glyceryl monooleate and glyceryl monolinoleate. Eur. J. Pharm. Sci., 6:231-9, 1998.
24. Nylander, T.; Mattisson, C.; Razumas, V.; Miezis, Y. & Hakansson, B. A study of entrapped enzyme stability and substrate diffusion in a monglyceride-based cubic liquid crystalline phase. J. Colloid. Interface. Sci., 114:311-20, 1996.
25. Paavola, A.; Kilpelaine, I.; Yliruusi, J. & Rosenberg, P. Controlled release injectable liposomal gel of ibuprofen for epidural analgesia. Int. J. Pharm., 199:85-93, 2000.
26. Park, H. & Park, K. Biocompatibility issues of implantable drug delivery. Pharm. Res., 13:1770-6, 1996.
27. Reddi, A. H. Bone morphogenetic proteins: an unconventional approach to isolation of first mammalian morphogens. Cytokine Growth Factor Rev., 8:11-20, 1997.
28. Reddi, A. H. Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nature. Biotechnol., 16:247-52, 1998.
29. Ruhe, P. Q.; Hedberg, E. L.; Padron, N. T.; Spauwen, P. H.; Jansen, J. A. & Mikos, A. G. rhBMP-2 release from injectablepoly(DL-lactic-co-glycolic acid)/calcium-phosphate cement composites. J. Bone. Joint. Surg. Am. 85A(Suppl 3):75-81, 2003.
30. Rutherford, R. B. & Gu, K. Treatment of inflamed ferret dental pulps with recombinant bone morphogenetic protein-7. Eur. J. Oral. Sci., 108:202-6, 2000.
31. Saad, B.; Kuboki, Y.; Welti, M.; Uhlschmid, G.K.; Neuenschwander, P. & Suter, U.W. DegraPol-foam: A degradable and highly porous polyesterurethane foam as a new substrate for bone formation. Artif. Organs, 24:939-45, 2000.
32. Schmolka, I.V. Artificial skin. I. Preparation and properties of pluronic F-127 gels of treatment of burns. J. Biomed. Mater. Res., 6:571-82, 1972.
33. Shah, J. C.; Dadhale, Y. & Chilukuri, D. M. Cubic phase gels as drug delivery systems. Adv. Drug. Deliv. Rev., 47:229-50, 2001.
34. Sigurdsson, T. J.; Lee, M. B.; Kubota, K.; Turek, T. J.; Wozney, J. M. & Wikesjo, U. M. Periodontal repair in dogs: Recombinant human bone morphogenetic protein-2 significantly enhances periodontal regeneration. J. Periodontol., 66:131-8, 1995.
35. Turchiello, R. F.; Vena, F. C. B.; Maillard, P. H.; Souza, C. S.; Bentley, M. V. L. B. & Tedesco, A. C. Cubic phase gel as a drug delivery system for topical application of 5-ALA, its ester derivatives and m-THPC in photodynamic therapy (PDT). Photochem. Photobiol., 70:1-6, 2003.
36. Uludag, H.; Friess, W.; Williams, D.; Porter, T.; Timony, G.; D'Augusta, D.; Blake, C.; Palmer, R.; Biron, B. & Wozney, J. rhBMP-collagen sponges as osteoinductive devices: Effects of in vitro sponge characteristics and protein pI on in vivo rhBMP pharmacokinetics. Ann. NY. Acad. Sci., 875:369-78, 1999.
37. Uludag, H.; Gao, T.; Porter, T. J.; Friess, W. & Wozney, J.M. Delivery systems for BMPs: Factors contributing to protein retention at an application site. J. Bone. Joint. Surg. Am., 83A (Suppl 1):S128-S35, 2001.
38. Vehof, J.W.; Fisher, J. P.; Dean, D.; van der Waerden, J. P.; Spauwen, P. H.; Mikos, A.G. & Jansen, J. A. Bone formation in transforming growth factor -1-coated porous poly(propylene fumarate) scaffolds. J. Biomed. Mater. Res., 60:241-51, 2002.
39. Veyries, M. L.; Couarraze, G.; Geiger, S.; Agnely, F.; Massias, L.; Kunzli, B.; Faurisson, F. & Rouveix B. Controlled release of vancomycin from Poloxamer 407 gels. Int. J. Pharm., 192:183-93, 1999.
40. Wang, E. A.; Rosen, V.; D'Alessandro, J. S.; Bauduy, M.; Cordes, P.; Harada, T.; Israel, D. I.; Hewick, R .M.; Kerns, K. M.; LaPan, P.; Luxenberg, D. P.; Mc Quaid, D.; Moutsatsos, I. K.; Nove, J. & Wozney, J. M. Recombinant human bone morphogenetic protein induces bone formation. Proc. Nat. Acad. Sci. USA., 87: 2220-4, 1990.
41. Whang, K.; Tsai, D. C.; Nam, E. K.; Aitken, M.; Sprague, S. M.; Patel, P. K. & Healy, K. E. Ectopic bone formation via rhBMP-2 delivery from porous bioabsorbable polymer scaffolds. J. Biomed. Mater. Res., 42: 491-9, 1998.
42. Winn, S.R.; Uludag, H. & Hollinger, J. O. Carrier systems for bone morphogenetic proteins. Clin. Orthop., 357:S95-S106, 1999.
43. Wozney, J. M. & Rosen, V. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin. Orthop., 346:26-37, 1998.
44. Yang, X.; Tare, R. S.; Partridge, K. A.; Roach, H. I.; Clarke, N. M.; Howdle, S. M.; Shakesheff, K. M. & Oreffo, R. O. Induction of human osteoprogenitor chemotaxis, proliferation, differentiation, and bone formation by osteoblast stimulating factor-1/pleiotrophin: Osteoconductive biomimetic scaffolds for tissue engineering. J. Bone. Miner. Res., 18:47-57, 2003.
45. Yasko, A.W.; Lane, J. M.; Fellinger, E. J.; Rosen, V.; Wozney, J. M. & Wang, E. A. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological and biomechanical study in rats. J. Bone. Joint Surg., 74:659-71, 1992.
46. Ziegler, J.; Mayr-Wohlfart, U.; Kessler, S.; Breitig, D. & Gunther, K. P. Adsorption and release properties of growth factors from biodegradable implants. J. Biomed. Mater. Res., 59:422-8, 2002.